Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000010

CEO bought 213,000 shares at an average $0.02 ($4,807)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

30 lines
Date Transaction Shares Price Value Owned after D/I
2019-02-12 Purchase : show line 1 in the form +1,000 $0.02 $22 21,132,623 D
2019-02-12 Purchase : show line 2 in the form +5,000 $0.02 $111 21,137,623 D
2019-02-12 Purchase : show line 3 in the form +2,500 $0.02 $58 21,140,123 D
2019-02-12 Purchase : show line 4 in the form +2,500 $0.02 $58 21,142,623 D
2019-02-12 Purchase : show line 5 in the form +5,000 $0.02 $115 21,147,623 D
2019-02-12 Purchase : show line 6 in the form +10,000 $0.02 $229 21,157,623 D
2019-02-12 Purchase : show line 7 in the form +5,000 $0.02 $113 21,162,623 D
2019-02-12 Purchase : show line 8 in the form +5,000 $0.02 $114 21,167,623 D
Open-market purchases · 213,000 sh · avg $0.02 · $4,807
Loading xslF345X03/primary_doc.xml…